Cargando…
Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD
Alzheimer’s disease (AD) is a neurodegenerative disease accompanied by progressive cognitive and memory dysfunction due to disruption of normal electrotonic properties of neurons and neuronal loss. The Na,K-ATPase interaction with beta amyloid (Aβ) plays an important role in AD pathogenesis. It has...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313104/ https://www.ncbi.nlm.nih.gov/pubmed/35884966 http://dx.doi.org/10.3390/biomedicines10071663 |
_version_ | 1784753997278609408 |
---|---|
author | Adzhubei, Alexei A. Tolstova, Anna P. Strelkova, Maria A. Mitkevich, Vladimir A. Petrushanko, Irina Yu. Makarov, Alexander A. |
author_facet | Adzhubei, Alexei A. Tolstova, Anna P. Strelkova, Maria A. Mitkevich, Vladimir A. Petrushanko, Irina Yu. Makarov, Alexander A. |
author_sort | Adzhubei, Alexei A. |
collection | PubMed |
description | Alzheimer’s disease (AD) is a neurodegenerative disease accompanied by progressive cognitive and memory dysfunction due to disruption of normal electrotonic properties of neurons and neuronal loss. The Na,K-ATPase interaction with beta amyloid (Aβ) plays an important role in AD pathogenesis. It has been shown that Na,K-ATPase activity in the AD brain was significantly lower than those in age-matched control brain. The interaction of Aβ(42) with Na,K-ATPase and subsequent oligomerization leads to inhibition of the enzyme activity. In this study interaction interfaces between three common Aβ(42) isoforms, and different conformations of human Na,K-ATPase (α1β1) have been obtained using molecular modeling, including docking and molecular dynamics (MD). Interaction sites of Na,K-ATPase with Aβ(42) are localized between extracellular parts of α- and β- subunits and are practically identical for Na,K-ATPase at different conformations. Thermodynamic parameters for the formation of Na,K-ATPase:Aβ(42) complex at different conformations acquired by isothermal titration calorimetry (ITC) are similar, which is in line with the data of molecular modeling. Similarity of Na,K-ATPase interaction interfaces with Aβ in all conformations allowed us to cross-screen potential inhibitors for this interaction and find pharmaceutical compounds that could block it. |
format | Online Article Text |
id | pubmed-9313104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93131042022-07-26 Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD Adzhubei, Alexei A. Tolstova, Anna P. Strelkova, Maria A. Mitkevich, Vladimir A. Petrushanko, Irina Yu. Makarov, Alexander A. Biomedicines Article Alzheimer’s disease (AD) is a neurodegenerative disease accompanied by progressive cognitive and memory dysfunction due to disruption of normal electrotonic properties of neurons and neuronal loss. The Na,K-ATPase interaction with beta amyloid (Aβ) plays an important role in AD pathogenesis. It has been shown that Na,K-ATPase activity in the AD brain was significantly lower than those in age-matched control brain. The interaction of Aβ(42) with Na,K-ATPase and subsequent oligomerization leads to inhibition of the enzyme activity. In this study interaction interfaces between three common Aβ(42) isoforms, and different conformations of human Na,K-ATPase (α1β1) have been obtained using molecular modeling, including docking and molecular dynamics (MD). Interaction sites of Na,K-ATPase with Aβ(42) are localized between extracellular parts of α- and β- subunits and are practically identical for Na,K-ATPase at different conformations. Thermodynamic parameters for the formation of Na,K-ATPase:Aβ(42) complex at different conformations acquired by isothermal titration calorimetry (ITC) are similar, which is in line with the data of molecular modeling. Similarity of Na,K-ATPase interaction interfaces with Aβ in all conformations allowed us to cross-screen potential inhibitors for this interaction and find pharmaceutical compounds that could block it. MDPI 2022-07-11 /pmc/articles/PMC9313104/ /pubmed/35884966 http://dx.doi.org/10.3390/biomedicines10071663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Adzhubei, Alexei A. Tolstova, Anna P. Strelkova, Maria A. Mitkevich, Vladimir A. Petrushanko, Irina Yu. Makarov, Alexander A. Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD |
title | Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD |
title_full | Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD |
title_fullStr | Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD |
title_full_unstemmed | Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD |
title_short | Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD |
title_sort | interaction interface of aβ(42) with human na,k-atpase studied by md and itc and inhibitor screening by md |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313104/ https://www.ncbi.nlm.nih.gov/pubmed/35884966 http://dx.doi.org/10.3390/biomedicines10071663 |
work_keys_str_mv | AT adzhubeialexeia interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd AT tolstovaannap interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd AT strelkovamariaa interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd AT mitkevichvladimira interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd AT petrushankoirinayu interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd AT makarovalexandera interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd |